Outlook Therapeutics risks Nasdaq delisting after 30-day sub-$1 bid-price stretch

Bitget2026/09/30 20:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Outlook Therapeutics received a Nasdaq notice for failing the $1.00 minimum bid price rule, following 30 straight business days below $1.00.
Shares remain listed on the Nasdaq Capital Market while the company has until March 24, 2027 to regain compliance.
Compliance requires a closing bid price of at least $1.00 for 10 consecutive business days before the deadline.
Failure to cure could trigger a delisting determination, with a possible appeal to a Nasdaq hearings panel.
An additional 180-day cure period may be available, including via a reverse stock split, subject to eligibility.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Outlook Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-112356), on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Outlook Therapeutics risks Nasdaq delisting after 30-day sub-$1 bid-price stretch

You may also like

Crypto prices